KRISTINE CROUCH: Open Payments
NPI 1699490748 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 21 payments from 10 companies in 2025. Trend: 2023 $425 · 2024 $487 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $109 |
| ABBVIE INC. | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Abbott Laboratories | 2 | $57 |
| Amgen Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, JARDIANCE, Ozempic, FREESTYLE LIBRE 3, ELIQUIS, OTEZLA, Rybelsus, Dexcom G6 Transmitter.
Industry payments across NV — which companies pay providers there.
